Control Bionics Statistics
Total Valuation
Control Bionics has a market cap or net worth of AUD 11.49 million. The enterprise value is 11.33 million.
Market Cap | 11.49M |
Enterprise Value | 11.33M |
Important Dates
The last earnings date was Friday, August 22, 2025.
Earnings Date | Aug 22, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Control Bionics has 294.61 million shares outstanding. The number of shares has increased by 126.86% in one year.
Current Share Class | 294.61M |
Shares Outstanding | 294.61M |
Shares Change (YoY) | +126.86% |
Shares Change (QoQ) | +9.11% |
Owned by Insiders (%) | 19.65% |
Owned by Institutions (%) | 5.81% |
Float | 114.48M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.63 |
PB Ratio | 2.09 |
P/TBV Ratio | 7.03 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.85 |
EV / Sales | 1.61 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.08.
Current Ratio | 1.24 |
Quick Ratio | 1.00 |
Debt / Equity | 0.08 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -54.33 |
Financial Efficiency
Return on equity (ROE) is -103.74% and return on invested capital (ROIC) is -56.18%.
Return on Equity (ROE) | -103.74% |
Return on Assets (ROA) | -42.88% |
Return on Invested Capital (ROIC) | -56.18% |
Return on Capital Employed (ROCE) | -104.25% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.82 |
Inventory Turnover | 4.99 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.95% in the last 52 weeks. The beta is 0.02, so Control Bionics's price volatility has been lower than the market average.
Beta (5Y) | 0.02 |
52-Week Price Change | -58.95% |
50-Day Moving Average | 0.04 |
200-Day Moving Average | 0.04 |
Relative Strength Index (RSI) | 48.41 |
Average Volume (20 Days) | 72,978 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Control Bionics had revenue of AUD 7.04 million and -6.11 million in losses. Loss per share was -0.02.
Revenue | 7.04M |
Gross Profit | 5.01M |
Operating Income | -5.92M |
Pretax Income | -6.11M |
Net Income | -6.11M |
EBITDA | -5.20M |
EBIT | -5.92M |
Loss Per Share | -0.02 |
Balance Sheet
The company has 594,733 in cash and 435,398 in debt, giving a net cash position of 159,335 or 0.00 per share.
Cash & Cash Equivalents | 594,733 |
Total Debt | 435,398 |
Net Cash | 159,335 |
Net Cash Per Share | 0.00 |
Equity (Book Value) | 5.51M |
Book Value Per Share | 0.02 |
Working Capital | 619,381 |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | -302,327 |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 71.14%, with operating and profit margins of -84.10% and -86.77%.
Gross Margin | 71.14% |
Operating Margin | -84.10% |
Pretax Margin | -86.77% |
Profit Margin | -86.77% |
EBITDA Margin | -73.82% |
EBIT Margin | -84.10% |
FCF Margin | n/a |
Dividends & Yields
Control Bionics does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -126.86% |
Shareholder Yield | n/a |
Earnings Yield | -53.17% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |